Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients
1 other identifier
interventional
102
1 country
1
Brief Summary
The positive effects of exercise on ocular health are known, but modern lifestyles have made it difficult to incorporate physical activity into the daily lives of the Chinese population. Recent studies suggest that exercise plays an important role in lowering intraocular pressure (IOP) by protecting retinal ganglion cells (RGCs) in glaucoma patients as well as other potential neuroprotective benefits. Increasing the amount of physical activity within the Chinese glaucoma population may have marked effects on health outcomes and coincides with the Chinese government's efforts to make exercise an urgent public health priority. There is a need for innovative, cost-effective, and proven interventions to promote exercise behavior change and social media platforms may be able to fill this niche. WeChat is China's largest and most frequently used social media and messaging application with an estimated 570 million users. The platform has been found to be a useful tool in healthcare settings to promote weight-loss, health literacy, and patient adherence in Chinese populations. This study is a 5-weeks randomized control trial with three total study visits. 80 patients from an academic glaucoma clinic in Wenzhou Medical College will be randomized into two groups. The intervention group will be enrolled into an Official WeChat Group and receive periodic reminders to exercise, health education materials, and motivational incentives. The control group will receive weekly reminders and leaflets at the first clinic visit. Patients' daily step data will be monitored using an Accelerometer WGT3X-BT. The intervention duration will include an initial clinic visit, a one-week follow-up after wearing the accelerometer, and then a subsequent one-month follow-up visit after wearing the accelerometer. At the one-week visit the patient will be randomized and at the subsequent one-month visit there will be a close-out discussion about the study. In addition to collecting step data at clinic visits, investigators will also measure patients' visual field tests, optical coherence tomography angiography (angio-OCT), and intraocular pressure (IOP) using Goldmann Tonometry. The investigators' hypothesis is that using an Official WeChat Patient Group will be a robust and effective stimulus to increase physical exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2018
CompletedFirst Posted
Study publicly available on registry
June 25, 2018
CompletedStudy Start
First participant enrolled
June 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2018
CompletedJanuary 15, 2019
January 1, 2019
5 months
May 29, 2018
January 14, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy of using WeChat as an intervention to increase physical activity in Chinese glaucoma patients
The primary outcome variable will be the number of daily steps taken over the course of one month for each participant. This outcome will be measured by having participants wear the Accelerometer WGT3X-BT, from which we can collect steps data. From this primary outcome measure we will also assess the change in number of steps taken comparing the first week to the following month after the intervention. Assuming mean enrollment number of steps per day is 9,302.29, we can detect an average increase of 2,500 steps per day with alpha set to 0.05 with 80% power.
5 weeks
Secondary Outcomes (1)
Time spent in moderate to vigorous physical activity
5 weeks
Study Arms (2)
Intervention Group
EXPERIMENTALThe intervention group will be enrolled into a WeChat Group to receive reminders to exercise and health education materials.
Control Group
ACTIVE COMPARATORControls will receive a handout telling them to increase walking and that walking may be helpful for the eye at the return visit.
Interventions
Consenting participants will be randomized to either the intervention or the control arm after successfully wearing an accelerometer for one week. The WeChat Group will be a community forum to share information, encourage each other, and receive communications from the study team. In addition, the study team will disseminate the following information through the group: 1. Daily/Weekly Reminders to exercise 2. Health education materials regarding glaucoma and general health and exercise 3. Motivational content 4. Surveys to gauge what information participants found most interesting and useful to help them exercise
Study participants in the control group will receive a handout telling them to increase walking and will be counseled that walking may be helpful for the eye at the return visit
Eligibility Criteria
You may qualify if:
- Glaucoma diagnosis
- Age 40 years and above
- Ability to sign informed consent
- Ability to use WeChat
You may not qualify if:
- Patients with severe heart, lung, or kidney disease which may prevent them from exercising
- Patients who self-report walking 12,000 steps or more per day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- Wenzhou Medical Universitycollaborator
Study Sites (1)
The affiliated eye hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Friedman, MD, MPH, PhD
Johns Hopkins University
- PRINCIPAL INVESTIGATOR
Yuanbo Liang, MD, PhD
Clinical & Epidemiological Eye Research Centre, The affiliated eye hospital of Wenzhou Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 29, 2018
First Posted
June 25, 2018
Study Start
June 25, 2018
Primary Completion
November 26, 2018
Study Completion
November 26, 2018
Last Updated
January 15, 2019
Record last verified: 2019-01